Veterinary medicines and feed additives in the environment following use in the poultry industry

家禽业使用后环境中的兽药和饲料添加剂

基本信息

  • 批准号:
    2743336
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Studentship
  • 财政年份:
    2022
  • 资助国家:
    英国
  • 起止时间:
    2022 至 无数据
  • 项目状态:
    未结题

项目摘要

Veterinary medicines are a mainstay of modern farming practice and are widely used to treat disease and to protect the health of animals. However, following their use these chemicals can be inadvertently introduced into the environment where they present an ecosystem and human health risk. Veterinary medicines such as antibiotics are biologically active chemicals designed to elicit effects and this potency is not lost when these chemicals enter the environment. Antibiotics administered to poultry and livestock for example, along with feed additives, can make their way in soil systems by direct release in animal waste products. Therefore, before any new medicine can be brought to market it has to undergo an authorisation process which involves an environmental risk assessment. Environmental risk assessments consider the likely exposure routes, environmental fate and behaviour of the chemical. Nevertheless, most research to date evaluating veterinary medicine degradation has focussed on liquid manures and the fate of veterinary medicines in poultry litter remains largely unknown. There is also a significant knowledge gap surrounding the fate of feed additives administered to livestock. The poultry industry continues to grow and the development of intensive production units represents a threat to the environment. Poultry manure is very different matrix to liquid manures with a lower water content and is typically aerobic. Differences in properties such as this have the potential to alter the fate and behaviour of chemicals in the manure itself and ultimately the risk of these chemicals when they are introduced into the environment. This project will address this significant knowledge gap by generating new understanding around the variability and influence of properties on the degradation of veterinary medicines and feed additives. Working in collaboration with scientists at Fera Science Limited will enable access to state-of-the-art instrumentation, laboratories and specialist expertise in environmental risk assessment. A key aspect of this project will build on previous findings which have demonstrated that antibiotics can affect soil microbial community composition and structure to understand how manure laced with antibiotic residues can influence soil microorganisms by changing their enzyme activity and ability to metabolize different carbon sources, as well as by altering the overall microbial biomass and the relative abundance of different groups. This topic urgently warrants further investigation given the increasing use of organic fertilisers in agriculture and the demand of veterinary medicines. Aim and objectivesThe overall aim of this project is to better understand the fate and effects of veterinary medicines in manure-soil systems. This will be achieved using a combination of an experimental approach in the laboratory and field trials utilising facilities available at the University of Leeds farm and Fera Science Limited. The specific objectives are to:1. Characterise the degradation of veterinary medicines and feed additives in poultry manure 2. Develop better understanding of the variability and property influence of manure type on degradation3. Investigate the impact of different manure types of soil-plant interactions including impacts on soil microbial biomass and the relative abundance of different groups soil microorganisms.4. Assess manure and/or soil samples for associated Antimicrobial Resistant (AMR) Bacteria or genes. This could be by; isolation of taxa or interest followed by phenotypic screening or Whole Genome Sequencing; qPCR of target AMR genes, or non-targeted High Throughput Sequencing of samples.
兽药是现代农业实践的支柱,广泛用于治疗疾病和保护动物健康。然而,这些化学品在使用后可能会无意中被引入环境,对生态系统和人类健康构成风险。抗生素等兽药是具有生物活性的化学品,旨在引起影响,当这些化学品进入环境时,这种效力不会丧失。例如,对家禽和家畜施用的抗生素,沿着饲料添加剂,可以通过直接释放到动物废物中而进入土壤系统。因此,在任何新药上市之前,都必须经过一个涉及环境风险评估的授权程序。环境风险评估考虑了化学品的可能接触途径、环境归宿和行为。然而,迄今为止,大多数评价兽药降解的研究都集中在液体粪便上,兽药在家禽粪便中的命运在很大程度上仍然未知。关于给牲畜使用的饲料添加剂的命运,也存在着重大的知识差距。家禽业继续增长,集约化生产单位的发展对环境构成威胁。家禽粪便是非常不同的基质液体粪便具有较低的水含量,通常是有氧的。这种性质的差异有可能改变粪肥本身中化学品的命运和行为,并最终改变这些化学品进入环境时的风险。该项目将通过对兽药和饲料添加剂降解特性的可变性和影响产生新的理解来解决这一重大的知识差距。与Fera Science Limited的科学家合作,将使他们能够获得最先进的仪器、实验室和环境风险评估方面的专业知识。该项目的一个关键方面将建立在以前的研究结果的基础上,这些研究结果表明抗生素可以影响土壤微生物群落的组成和结构,以了解含有抗生素残留物的粪肥如何通过改变酶活性和代谢不同碳源的能力来影响土壤微生物,以及通过改变整体微生物生物量和不同群体的相对丰度。鉴于有机肥料在农业中的使用越来越多以及对兽药的需求,这一主题迫切需要进一步研究。本项目的总体目标是更好地了解兽药在粪便-土壤系统中的归宿和影响。这将通过实验室实验方法和田间试验相结合来实现,田间试验利用了利兹大学农场和Fera Science Limited的设施。具体目标是:1.家禽粪便中兽药和饲料添加剂的降解特性2.更好地了解粪便类型对降解的可变性和性质影响3。研究不同类型有机肥对土壤-植物相互作用的影响,包括对土壤微生物生物量和不同类群土壤微生物相对丰度的影响.评估粪肥和/或土壤样品中相关的抗菌素耐药性(AMR)细菌或基因。这可能是由;分离分类群或感兴趣的分类群,然后进行表型筛选或全基因组测序;靶AMR基因的qPCR,或样品的非靶向高重复序列测序。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    --
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship

相似海外基金

Micro-manufacturing of tissue patterned organ-chips for accelerated deployment of new medicines (Patterned OrganChips)
用于加速新药部署的组织图案化器官芯片的微制造(图案化器官芯片)
  • 批准号:
    EP/Z531261/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Transforming the future use of injectable medicines outside the hospital: Increasing capacity in the NHS
改变未来医院外注射药物的使用:提高 NHS 的能力
  • 批准号:
    EP/X025470/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Polymer particle catalysed miRNA therapeutics for HGSOC precision medicines
用于 HGSOC 精准医学的聚合物颗粒催化 miRNA 疗法
  • 批准号:
    MR/Z503927/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Smart biomanufacturing for genomic medicines
基因组药物的智能生物制造
  • 批准号:
    EP/X025446/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Identifying novel & repurposing drug targets for Atrial Fibrillation MEDicines
识别小说
  • 批准号:
    EP/Z000211/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
ASD3MAP: Amorphous Solid Dispersion Digital Design and Manufacturing Platform for rapid and resource-efficient development of bioavailable medicines
ASD3MAP:非晶固体分散体数字设计和制造平台,用于快速、资源高效地开发生物可利用药物
  • 批准号:
    10078996
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
Development of efficient synthetic methods for artificial nucleic acids aimed at improving activity and reducing toxicity of oligonucleotide medicines
开发人工核酸的有效合成方法,旨在提高寡核苷酸药物的活性并降低毒性
  • 批准号:
    23K04930
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Medicine Bundle for Two-Spirit and Indigiqueer Peoples: Expanding and Adapting an Indigenous-Led Sexual Health Testing Program from Colonial British Columbia Across Turtle Island
为两种精神和土著民族提供的药物组合:在海龟岛上扩展和调整不列颠哥伦比亚殖民地的土著主导的性健康测试计划
  • 批准号:
    487633
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了